OpenVSafe by OpenVAERS
Search V-safe

C7A-35460-44753

4 vaccinations 17 coded responses 40 check-ins 17 free-text entries 0 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
953 / CA
Registered
2021-03-28
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino
Registered dependents
34L-87716-93312 Child or adolescent in my care · Female · 2021-11-23
EZU-33440-19034 Child or adolescent in my care · Male · 2021-11-23

Timeline

  1. 2021-03-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-27
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-28
    Registered in v-safe
  4. 2021-03-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Left clavicular lymphadenopathy with tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Left supraclavicular lymphadenopathy with tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Good · Diarrhea
    Free text: Left supraclavicular lymphadenopathy with improved tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Good
    Free text: Continued improvement of left supraclavicular lymphadenopathy with improving tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Improving left supraclavicular lymphadenopathy with no tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Improving left supraclavicular lymphadenopathy with no tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-03
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: 2 cm left supraclavicular lymphadenopathy without tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-17
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-04-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-05-02
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-26
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-09-26
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-11-21
    Dose 3 — Pfizer-BioNTech
  19. 2021-11-23
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Axilla and subclavicular lymphadenopathy with tenderness
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-11-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Axilla and subclavicular lymphadenopathy and tenderness
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-11-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Swelling · Fatigue or tiredness
    Free text: Subclavicular & Axilla lymphadenopathy with tenderness
    MedDRA releases: 2024-11 · check-in free text available
  22. 2021-11-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Mild subclavicular lymphadenopathy with no tenderness
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-11-28
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-12-05
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-12-14
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-12-19
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-12-26
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-01-02
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-02-20
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-05-22
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-11-12
    Dose 4 — Pfizer-BioNTech
  32. 2022-11-12
    Health check-in — day 0, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  33. 2022-11-13
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Lymphadenopathy with mild tenderness
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-11-14
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Good
    Free text: Axillary lymphadenopathy with moderate tenderness and subclavicular lymphadenopathy without tenderness
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-11-15
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Fever
    Free text: Axillary lymphadenopathy with mod tenderness and subclavicular lymphadenopathy without tenderness
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-11-17
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Subclavicular lymphadenopathy without tenderness and Axillary lymphadenopathy without tenderness
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-11-18
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Subclavicular lymphadenopathy without tenderness
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-11-19
    Survey response — day 7, dose 4
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Supraclavicular lymphadenopathy without tenderness
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-11-26
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  40. 2022-12-03
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-12-10
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-12-18
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-12-24
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  44. 2023-02-12
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  45. 2023-05-13
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-06Pfizer-BioNTech
22021-03-27Pfizer-BioNTech
32021-11-21Pfizer-BioNTech No
42022-11-12Pfizer-BioNTech No

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-28

Systemic reaction (other): Left clavicular lymphadenopathy with tenderness

2021-03-29

Systemic reaction (other): Left supraclavicular lymphadenopathy with tenderness

2021-03-30

Systemic reaction (other): Left supraclavicular lymphadenopathy with improved tenderness

2021-03-31

Systemic reaction (other): Continued improvement of left supraclavicular lymphadenopathy with improving tenderness

2021-04-01

Systemic reaction (other): Improving left supraclavicular lymphadenopathy with no tenderness

2021-04-02

Systemic reaction (other): Improving left supraclavicular lymphadenopathy with no tenderness

Release 6 — day 7, dose 2

2021-04-03

Systemic reaction (other): 2 cm left supraclavicular lymphadenopathy without tenderness

Release 10 — days 1–6 daily, dose 3

2021-11-23

Systemic reaction (other): Axilla and subclavicular lymphadenopathy with tenderness

2021-11-24

Systemic reaction (other): Axilla and subclavicular lymphadenopathy and tenderness

2021-11-25

Systemic reaction (other): Subclavicular & Axilla lymphadenopathy with tenderness

2021-11-27

Systemic reaction (other): Mild subclavicular lymphadenopathy with no tenderness

Release 12 — days 1–6 daily, dose 4

2022-11-13

Systemic reaction (other): Lymphadenopathy with mild tenderness

2022-11-14

Systemic reaction (other): Axillary lymphadenopathy with moderate tenderness and subclavicular lymphadenopathy without tenderness

2022-11-15

Systemic reaction (other): Axillary lymphadenopathy with mod tenderness and subclavicular lymphadenopathy without tenderness

2022-11-17

Systemic reaction (other): Subclavicular lymphadenopathy without tenderness and Axillary lymphadenopathy without tenderness

2022-11-18

Systemic reaction (other): Subclavicular lymphadenopathy without tenderness

Release 12 — day 7, dose 4

2022-11-19

Systemic reaction (other): Supraclavicular lymphadenopathy without tenderness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROLymph node pain · · ✓
SROLymphadenopathy ✓ ✓ ✓
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release